Current drug discovery is dominated by target / cell-based approaches that fail to capture the complexity of biology at organ and organism levels.
At Organ and Organism levels, we remain reliant on animal models and human trials, which contribute to high failure rates, excessive costs, and lengthy timelines.Current drug discovery is not efficient Current drug discovery failure rate is about 90%, costs more than $2B per drug and takes more than 10 years to get approval.
Phenotypic Target based
Technology GAP in drug discovery Current generative AI advancements incapable of handling biological complexities at all scales leading to a technology GAP. Technology GAP
Organome Platform Organome:
The first AI organism level model
Trained on multimodal omics data to build the first generative AI platform to simulate biology at all scales
